ArticleFrontiers in oncology2023

Camrelizumab plus gemcitabine and oxaliplatin for the treatment of advanced intrahepatic cholangiocarcinoma: a bi-centric observational retrospective study.

Yu-Qing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.